New tech wound healing

Safe and effective – wound healing preparation reaches clinical phase II: APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells.

APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers (non-healing foot ulcers). The Data Safety Monitoring Board has therefore recommended continuation into a Phase II clinical trial. This represents a major success for the wound healing preparation developed at MedUni Vienna. APO-2 contains the secretome … read more